Apricus Biosciences (APRI) Reports Q3 Loss of $0.19

Apricus Biosciences (NASDAQ: APRI) reported Q3 EPS of ($0.19), versus ($1.00) reported last year. Revenue for the quarter came in at $4.3 million, versus $1.3 million reported last year.

For earnings history and earnings-related data on Apricus Biosciences (APRI) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c